#Medtech Market in Europe

[foxxfin]

Dive into the Medtech Market in Europe with FOXX. Discover key players, emerging trends, and opportunities in the medical technology sector across Europe, empowering your business with valuable insights and analytics.

[bloggerpaula]

How European Venture Capitalists Are Adapting to the Deep Tech Boom

The deep tech revolution is reshaping industries across the globe, and Europe is no exception. However, a significant challenge for European Venture Capitalist (VC) firms lies not in the availability of funds but in the ability to identify and support the right deep tech organizations. A knowledge gap among investors has made it difficult to evaluate these emerging technologies effectively, slowing down potential investments.

Bridging the Knowledge Gap in Deep Tech Investment

Unlike traditional startups, deep tech companies operate in complex, research-intensive domains such as artificial intelligence (AI), quantum computing, robotics, cybersecurity, and machine learning. The sheer breadth of these fields makes it challenging for new Venture Capitalist to assess potential investments confidently. Despite this, many Venture Capitalists like Rajat Khare have recognized the potential of deep tech and have already begun making strategic moves.

European VC Firms Leading the Deep Tech Charge

Several forward-thinking VC firms in Europe have stepped up to support the deep tech boom. Angular Ventures, a UK-based firm founded in 2019 by Gil Dibner, focuses on early-stage deep tech enterprises in Europe and Israel. Similarly, Amadeus Capital Partners, headquartered in Cambridge, invests in startups across Europe and Latin America that have the potential to disrupt billion-dollar markets. As their CEO puts it, “We are attracted by companies that can disrupt existing billion-dollar markets, by either cost or performance, and we are supportive over a number of years as the technology is commercialized.”

Challenges in Deep Tech Investments

The difficulty for venture capitalists does not end with understanding deep tech. One of the biggest hurdles is aligning financial returns with the longer development cycles of deep tech startups. Unlike SaaS or MedTech businesses that follow conventional revenue patterns, deep tech startups operate on uncertain timelines and unpredictable market adoption rates.

As Rajat Khare, founder of Boundary Holding, puts it, “The possibility of particular new deep tech businesses succeeding, the best investments to make, or the speed at which their potential will be reached are all unknown at this time. But now, the sector is developing more swiftly than many experts anticipated.”

This sentiment is reflected in a recent survey where 70% of European investors admitted struggling to apply traditional investment metrics—such as annual recurring revenue or customer acquisition costs—to deep tech startups.

A Strategic Shift Toward Long-Term Investment

Despite these challenges, leading investment firms are actively working to adapt their strategies to fit deep tech’s unique growth trajectory. For instance, Boundary Holding, based in Luxembourg, has been consistently backing deep tech startups, recognizing that long-term research and innovation are crucial for future technological breakthroughs.

To succeed in this evolving landscape, VC firms must adopt a problem-solving mindset, similar to how the Internet transformed the IT industry in the 1980s. As more venture capitalists take the time to understand deep tech, refine investment strategies, and adjust financial expectations, Europe is poised to become a powerhouse for deep tech innovation.

The increasing interest in deep tech by European venture capitalists signals a shift toward sustainable, high-impact investments, ensuring that the region remains at the forefront of the next technological revolution.

[lovelypol]

🏗️ Precision Surgical Robotics: Market to Hit $10.5B by 2034

Precision Robotics for Surgery Market is revolutionizing healthcare by introducing advanced robotic systems designed to enhance surgical precision, efficiency, and patient outcomes. This sector includes robotic-assisted devices, surgical planning software, and post-operative analytics, aiming to minimize invasiveness, increase accuracy, and reduce recovery times. These advancements are transforming traditional surgical procedures, offering significant improvements in patient care and operational efficiency in healthcare facilities worldwide.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS11057 &utm_source=SnehaPatil&utm_medium=Article

Driven by technological progress and the growing demand for minimally invasive procedures, the market is expanding rapidly. The orthopedic surgery segment currently leads the market, propelled by the rising prevalence of musculoskeletal disorders and the need for highly precise surgical interventions. Cardiovascular surgery follows closely, as the increasing incidence of heart diseases and the demand for precise surgeries drive growth. Geographically, North America dominates the market, owing to its advanced healthcare infrastructure and high adoption rate of innovative technologies. Europe, particularly countries like Germany and the United Kingdom, is also witnessing substantial growth, as healthcare systems integrate more robotic solutions. Meanwhile, the Asia-Pacific region is poised for rapid growth due to increasing healthcare investments and rising awareness of the benefits of robotic surgery.

In 2023, the market reached a significant volume, with surgical robotics capturing a 45% market share, followed by robotic-assisted surgeries at 30% and minimally invasive systems at 25%. The adoption of robotic systems in orthopedic and cardiovascular procedures has been pivotal in driving this growth.

Key players like Intuitive Surgical, Stryker Corporation, and Medtronic are at the forefront, leading innovations and forging strategic partnerships. As AI and machine learning are integrated into surgical robotics, the market is set to grow further, with a projected annual growth rate of 10% over the next decade.

#SurgicalRobotics #PrecisionSurgery #RoboticSurgery #MinimallyInvasive #OrthopedicSurgery #CardiovascularSurgery #MedTech #AIinHealthcare #RoboticsInMedicine #HealthcareInnovation #MedicalTechnology #SurgeryInnovation #Telemanipulation #RoboticSystems #AdvancedSurgery #PostOperativeCare #HealthTech #RoboticAssistance #SurgicalPrecision #FutureOfSurgery #HealthcareEfficiency #MedicalDevices #SurgicalPlanning #RoboticArms #StrykerCorporation #IntuitiveSurgical #Medtronic

[petershagory]

Trends in the MedTech Industry

The medical devices industry continues to thrive, driven by the interplay of technological innovation, evolving healthcare needs, and regulatory changes. Investors worldwide, recognizing the societal and economic potential of medical technology (MedTech), have explored opportunities that address critical health challenges while promising significant returns.

One of the most transformative drivers of investment is artificial intelligence (AI). The integration of AI into medical devices has accelerated, with the technology revolutionizing diagnostics, predictive analytics, and surgical precision. AI-powered diagnostic tools are no longer a novelty; they have become a cornerstone in healthcare, offering unparalleled accuracy in analyzing medical images and predicting patient outcomes. Predictive analytics, supported by AI, enables earlier identification of health risks, fostering personalized treatment plans that alleviate the strain on healthcare systems.

Wearable technology is also reshaping patient engagement in healthcare. These devices empower individuals by offering tools for proactive health management, a trend amplified by consumer demand for personalized solutions. Remote patient monitoring (RPM) devices, which gained prominence during the pandemic, continue to evolve, making chronic care management more accessible and less reliant on frequent hospital visits. On the consumer front, health wearables have grown more sophisticated, incorporating advanced features such as ECG and blood oxygen monitoring. As these devices become more accurate and reliable, they are redefining healthcare delivery and capturing sustained investor interest.

Minimally invasive and non-invasive devices have also emerged as pivotal areas of focus. The preference for quicker recovery times and less postoperative discomfort has spurred innovation in this domain. Robotic-assisted surgical systems are at the forefront, offering unparalleled precision and expanding their applications. Non-invasive monitoring devices, such as continuous glucose monitors (CGMs), are providing alternatives that improve patient comfort while offering valuable data for healthcare optimization. These advancements align with patient demands and medical goals, creating a robust foundation for ongoing investment.

Imaging technologies, a cornerstone of diagnostics, are undergoing a transformative phase. Innovations in 3D and 4D imaging expand how medical professionals visualize the human body, enhancing diagnostic accuracy and surgical planning. The integration of AI into imaging technologies further amplifies their capabilities, enhancing anomaly detection and predictive accuracy. These advancements have drawn significant capital, with companies at the cutting edge poised to reshape diagnostic landscapes.

The regulatory landscape also plays a critical role in shaping medtech investment. Programs like the FDA’s Breakthrough Devices initiative expedite the approval of innovative technologies, reducing time-to-market, and attracting investor interest. In Europe, navigating the complexities of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) has become a differentiator for companies seeking leadership in the regional market. Globally, the push for regulatory harmonization promises to ease market entry, positioning firms adept at managing these changes as attractive investment opportunities.

Despite a vibrant landscape, medtech faces challenges. Funding for early-stage companies has become more selective, with venture capitalists prioritizing robust clinical evidence and scalability. Mergers and acquisitions (M&A) remain the predominant exit strategy, driven by market consolidation, access to innovation, and global expansion. Intellectual property (IP) continues to be a cornerstone of investment and M&A, serving as a barrier to entry and a source of value creation.

The integration of AI, coupled with advancements in data security and privacy, underscores the sector's digital transformation. While these technologies offer immense potential, they require robust cybersecurity measures to protect sensitive patient information and maintain regulatory compliance. The risk of patients suing healthcare organizations for breaching their confidentiality further emphasizes the need for proactive risk management.

[deshpandeisha]

Introduction to Ablation Systems: Overview and Applications

The global ablation systems market size was USD 5.75 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.6% during the forecast period. Increasing integration of ablation systems with imaging technologies and rising adoption of robotics and navigation technologies are major factors driving market revenue growth.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/2557

Competitive Terrain:

The global Ablation Systems industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Medtronic, Johnson & Johnson, Abbott, Boston Scientific Corporation, AngioDynamic, Olympus, Smith+Nephew, Stryker, Dornier MedTech, and Cynosure, LLC

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Ablation Systems market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Ablation Systems market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Ablation Systems market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/2557

Market Segmentations of the Ablation Systems Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Ablation Systems market on the basis of product, application, and region:

Segments Covered in this report are:

Device Technology Outlook (Revenue, USD Billion; 2019-2032)

Radiofrequency (RF) Devices

Ultrasound Devices

Others

Application Outlook (Revenue, USD Billion; 2019-2032)

Cancer Treatment

Ophthalmologic Treatment

Urological Treatment

Others

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals & Clinics

Ambulatory Surgical Centers (ASCs)

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/ablation-systems-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/2557

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[hauntedqueenking]

[ad_1] BANGKOK, THAILAND – Media OutReach Newswire – 27 December 2024 – The Ministry of Higher Education, Science, Research, and Innovation (MHESI), through the National Innovation Agency (Public Organization) or NIA, is forging ahead to support high-potential Thai startups and SMEs in the medical and health innovation sectors, granting them access to Germany, one of Europe’s largest and most significant MedTech markets. As part of the ‘Digital Innovation Business Development Programme for Connecting to International Markets and Funding in Europe,’ NIA has selected eight outstanding Thai medical and health innovation startups and SMEs that have received prior NIA backing. These companies will showcase their cutting-edge innovations at Medica 2024 in the Federal Republic of Germany. The initiative aims to propel Thai medical innovations to global prominence and establish stronger footholds in the European market. Medica 2024 offers a critical platform for connecting Thai innovators with international opportunities, reinforcing Thailand’s reputation as a global leader in medical and health innovation. Dr Krithpaka Boonfueng, Executive Director of the National Innovation Agency (Public Organisation), along with Professor Emeritus Dr Sirirurg Songsivilai, Chairman of the Board of Science, Research, and Innovation Promotion (GSRI), and a delegation of executives and staff from NIA, visited the exhibition booth showcasing the achievements of eight medical and health innovation startups supported by NIA. The visit took place at the Medica 2024 event in the Federal Republic of Germany. Dr. Krithpaka Boonfueng, Executive Director of the National Innovation Agency (Public Organization) or NIA, stated that NIA, in its role as a ‘Focal Conductor of Innovation,’ is dedicated to nurturing and enhancing the capabilities of Thai innovators to achieve sustainable growth. This commitment is guided by the ‘4G Approach’: Groom: Fostering and strengthening the potential of Thai innovators. Grant: Providing financial mechanisms to develop and scale innovative businesses to market readiness. Growth: Accelerating the expansion of both startups and SMEs in the innovation ecosystem. Global: Propelling Thai innovators onto the international stage. Thailand’s medical industry, a standout sector, benefits from one of the world’s top-ranking healthcare systems. The global MedTech market is projected to soar to 775.8 billion US dollars by 2029, with Germany emerging as a particularly promising market. Germany’s long-standing role as host of the world-renowned Medica trade fair for over 40 years underscores its importance. Recognised by experts as the largest medical trade exhibition globally, Medica attracts more than 6,100 exhibitors from 69 countries, solidifying its status as a pivotal platform for the medical and healthcare sectors. Dr Krithpaka added that the NIA is proud to participate in Medica 2024 under the theme ‘Meet Health. Future. People,’ hosted in the Federal Republic of Germany. As part of this prestigious event, eight outstanding Thai medical and healthcare innovation startups and SMEs, selected through a rigorous process, will showcase their pioneering solutions. These include: Eidy: A large language model (LLM) tailored for medical applications, distinguished by its specialised terminology and physician-like reasoning. It holds potential for developing chatbots designed to address specific medical queries. Ravis Technology: A platform for managing clinical research and data related to biopharmaceuticals, medical devices, and drugs. By leveraging technology to streamline data management, it saves time and costs. Pose Intelligence: A medical equipment management platform for hospitals, providing precise inventory control and central supply management. It reduces redundancy and minimises errors with its efficient systems. SOS Care: An innovative wound dressing made from silk protein combined with carboxymethyl cellulose (CMC) and glycerin. This flexible dressing promotes collagen production, accelerating wound healing. POPOLO: A device designed to band oesophageal varices caused by abnormal blood flow to the liver. This innovation enhances accessibility for Thai patients and reduces mortality rates. Orthopeasia: A cutting-edge platform for designing and producing spinal disc replacements using specialised software. Its innovation simplifies surgical procedures, ensuring smaller incisions, faster operations, and improved convenience for both surgeons and patients. BRE: A revolutionary two-step bathing sheet that eliminates the need for water and soap, providing a practical solution for patients unable to bathe, significantly enhancing their quality of life. Aquatrek Solution: A water treadmill, an advanced hydrotherapy device ideal for reducing the risks associated with exercise, particularly for the elderly. It minimises joint strain while supporting body weight, making it highly effective for rehabilitation and therapy. These eight groundbreaking innovations have garnered considerable interest from partners and potential collaborators across the United States, Europe, and Canada, seeking to exchange technologies and customer bases. Collaborative research opportunities, such as co-publishing with German academics, hosting researcher exchange programmes, or licensing specific or complete production technologies for German manufacturing, could significantly bolster the credibility of Thai medical devices. Research partnerships are a gateway to greater acceptance in the European market. Furthermore, studying attendee and exhibitor profiles at Medica 2024 offers invaluable insights for refining Thai innovations and devising strategic marketing approaches. These initiatives could stimulate investments, foster business matchmaking, and pave the way for cross-border collaborations, driving future advancements in medical innovation. Ms Maleepan Phasupong, from Ravis Technology Co Ltd, a developer of clinical research management platforms, shared her perspective on being selected to participate in the global medical and health innovation showcase Medica 2024. She highlighted that this prestigious event provided invaluable insights into the European market’s overall needs, particularly in the realms of digital solutions, health and physical care devices, and diagnostic tools. Beyond helping Thai startups align their innovations with market demands, it serves as a pivotal starting point for achieving real business partnerships. By showcasing Thailand’s research strengths, especially to Western countries increasingly interested in collaborative research with Thailand, the event bolstered international recognition. This growing interest is particularly evident in the West, where there is a notable trend towards exploring research partnerships in Thailand. During the event, the company secured discussions with five potential partners and clients, with follow-ups already underway. German STEM researchers, in particular, have expressed interest in exchanges with Thailand to reduce costs associated with services and production within Europe, such as clinical research expenses or medical device manufacturing. This highlights the tangible opportunities created through platforms like Medica, not only for networking but also for fostering deeper international collaboration and reducing operational costs. Mr Thanatpant Manosittisak of SOS Care Co Ltd, developer of silk-protein wound dressings, emphasised that Thai medical and health startups and SMEs have strong potential to thrive in global markets if provided with adequate support in terms of funding, resources, and technological development. He pointed out that Thailand’s lower production costs, compared to developed nations, present a competitive advantage. However, government support is crucial to propel these startups and SMEs into forming international collaborations and expanding their market and business networks. Such backing enhances their credibility and strengthens confidence in the quality and innovation of Thai products on the global stage. Mr Thanatpant expressed hope that participating in Medica 2024 would enable his company to secure distributors across Europe, Asia, and the Middle East, thereby driving further international market expansion. Hashtag: #NIA The issuer is solely responsible for the content of this announcement.(function(d, s, id) var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "//connect.facebook.net/en_US/all.js#xfbml=1"; fjs.parentNode.insertBefore(js, fjs); (document, 'script', 'facebook-jssdk')); [ad_2] Source link

[ezraworld1]

[ad_1] BANGKOK, THAILAND – Media OutReach Newswire – 27 December 2024 – The Ministry of Higher Education, Science, Research, and Innovation (MHESI), through the National Innovation Agency (Public Organization) or NIA, is forging ahead to support high-potential Thai startups and SMEs in the medical and health innovation sectors, granting them access to Germany, one of Europe’s largest and most significant MedTech markets. As part of the ‘Digital Innovation Business Development Programme for Connecting to International Markets and Funding in Europe,’ NIA has selected eight outstanding Thai medical and health innovation startups and SMEs that have received prior NIA backing. These companies will showcase their cutting-edge innovations at Medica 2024 in the Federal Republic of Germany. The initiative aims to propel Thai medical innovations to global prominence and establish stronger footholds in the European market. Medica 2024 offers a critical platform for connecting Thai innovators with international opportunities, reinforcing Thailand’s reputation as a global leader in medical and health innovation. Dr Krithpaka Boonfueng, Executive Director of the National Innovation Agency (Public Organisation), along with Professor Emeritus Dr Sirirurg Songsivilai, Chairman of the Board of Science, Research, and Innovation Promotion (GSRI), and a delegation of executives and staff from NIA, visited the exhibition booth showcasing the achievements of eight medical and health innovation startups supported by NIA. The visit took place at the Medica 2024 event in the Federal Republic of Germany. Dr. Krithpaka Boonfueng, Executive Director of the National Innovation Agency (Public Organization) or NIA, stated that NIA, in its role as a ‘Focal Conductor of Innovation,’ is dedicated to nurturing and enhancing the capabilities of Thai innovators to achieve sustainable growth. This commitment is guided by the ‘4G Approach’: Groom: Fostering and strengthening the potential of Thai innovators. Grant: Providing financial mechanisms to develop and scale innovative businesses to market readiness. Growth: Accelerating the expansion of both startups and SMEs in the innovation ecosystem. Global: Propelling Thai innovators onto the international stage. Thailand’s medical industry, a standout sector, benefits from one of the world’s top-ranking healthcare systems. The global MedTech market is projected to soar to 775.8 billion US dollars by 2029, with Germany emerging as a particularly promising market. Germany’s long-standing role as host of the world-renowned Medica trade fair for over 40 years underscores its importance. Recognised by experts as the largest medical trade exhibition globally, Medica attracts more than 6,100 exhibitors from 69 countries, solidifying its status as a pivotal platform for the medical and healthcare sectors. Dr Krithpaka added that the NIA is proud to participate in Medica 2024 under the theme ‘Meet Health. Future. People,’ hosted in the Federal Republic of Germany. As part of this prestigious event, eight outstanding Thai medical and healthcare innovation startups and SMEs, selected through a rigorous process, will showcase their pioneering solutions. These include: Eidy: A large language model (LLM) tailored for medical applications, distinguished by its specialised terminology and physician-like reasoning. It holds potential for developing chatbots designed to address specific medical queries. Ravis Technology: A platform for managing clinical research and data related to biopharmaceuticals, medical devices, and drugs. By leveraging technology to streamline data management, it saves time and costs. Pose Intelligence: A medical equipment management platform for hospitals, providing precise inventory control and central supply management. It reduces redundancy and minimises errors with its efficient systems. SOS Care: An innovative wound dressing made from silk protein combined with carboxymethyl cellulose (CMC) and glycerin. This flexible dressing promotes collagen production, accelerating wound healing. POPOLO: A device designed to band oesophageal varices caused by abnormal blood flow to the liver. This innovation enhances accessibility for Thai patients and reduces mortality rates. Orthopeasia: A cutting-edge platform for designing and producing spinal disc replacements using specialised software. Its innovation simplifies surgical procedures, ensuring smaller incisions, faster operations, and improved convenience for both surgeons and patients. BRE: A revolutionary two-step bathing sheet that eliminates the need for water and soap, providing a practical solution for patients unable to bathe, significantly enhancing their quality of life. Aquatrek Solution: A water treadmill, an advanced hydrotherapy device ideal for reducing the risks associated with exercise, particularly for the elderly. It minimises joint strain while supporting body weight, making it highly effective for rehabilitation and therapy. These eight groundbreaking innovations have garnered considerable interest from partners and potential collaborators across the United States, Europe, and Canada, seeking to exchange technologies and customer bases. Collaborative research opportunities, such as co-publishing with German academics, hosting researcher exchange programmes, or licensing specific or complete production technologies for German manufacturing, could significantly bolster the credibility of Thai medical devices. Research partnerships are a gateway to greater acceptance in the European market. Furthermore, studying attendee and exhibitor profiles at Medica 2024 offers invaluable insights for refining Thai innovations and devising strategic marketing approaches. These initiatives could stimulate investments, foster business matchmaking, and pave the way for cross-border collaborations, driving future advancements in medical innovation. Ms Maleepan Phasupong, from Ravis Technology Co Ltd, a developer of clinical research management platforms, shared her perspective on being selected to participate in the global medical and health innovation showcase Medica 2024. She highlighted that this prestigious event provided invaluable insights into the European market’s overall needs, particularly in the realms of digital solutions, health and physical care devices, and diagnostic tools. Beyond helping Thai startups align their innovations with market demands, it serves as a pivotal starting point for achieving real business partnerships. By showcasing Thailand’s research strengths, especially to Western countries increasingly interested in collaborative research with Thailand, the event bolstered international recognition. This growing interest is particularly evident in the West, where there is a notable trend towards exploring research partnerships in Thailand. During the event, the company secured discussions with five potential partners and clients, with follow-ups already underway. German STEM researchers, in particular, have expressed interest in exchanges with Thailand to reduce costs associated with services and production within Europe, such as clinical research expenses or medical device manufacturing. This highlights the tangible opportunities created through platforms like Medica, not only for networking but also for fostering deeper international collaboration and reducing operational costs. Mr Thanatpant Manosittisak of SOS Care Co Ltd, developer of silk-protein wound dressings, emphasised that Thai medical and health startups and SMEs have strong potential to thrive in global markets if provided with adequate support in terms of funding, resources, and technological development. He pointed out that Thailand’s lower production costs, compared to developed nations, present a competitive advantage. However, government support is crucial to propel these startups and SMEs into forming international collaborations and expanding their market and business networks. Such backing enhances their credibility and strengthens confidence in the quality and innovation of Thai products on the global stage. Mr Thanatpant expressed hope that participating in Medica 2024 would enable his company to secure distributors across Europe, Asia, and the Middle East, thereby driving further international market expansion. Hashtag: #NIA The issuer is solely responsible for the content of this announcement.(function(d, s, id) var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "//connect.facebook.net/en_US/all.js#xfbml=1"; fjs.parentNode.insertBefore(js, fjs); (document, 'script', 'facebook-jssdk')); [ad_2] Source link

[lsieurope]

Lessons from Building & Scaling Medtech Ventures Through Challenging Market Conditions 

At LSI Europe ‘23, a panel of industry leaders gathered to discuss the present and future of the medtech market. With over 120 years of medtech experience, industry veterans shared their unique perspectives on the shifting landscape, offering valuable insights for entrepreneurs and medical device investors.

Learn More: https://www.lsieuropesummit.com/news/lessons-from-building-scaling-medtech-ventures-through-challenging-market-conditions-insights-from-lsi-europe-23 

[janetushar1]

Disposable Ureteroscope Market to Hit $6215.90 Million by 2032

The global Disposable Ureteroscope Market was valued at USD 1990.08 Million in 2024 and it is estimated to garner USD 6215.90 Million by 2032 with a registered CAGR of 15.3% during the forecast period 2024 to 2032.

The report throws light on the competitive scenario of the global Disposable Ureteroscope Market to know the competition at global levels. Market experts also provided the outline of each leading player of the global Disposable Ureteroscope Market for the market, considering the key aspects such as the areas of operation, production, and product portfolio. In addition, the companies in the report are studied based on vital factors such as company size, market share, market growth, revenue, production volume, and profit.

The global Disposable Ureteroscope Market is fragmented with various key players. Some of the key players identified across the value chain of the global Disposable Ureteroscope Market include Boston Scientific Corporation, Richard Wolf GmbH, Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz GmbH, Smith & Nephew Inc., Pentax Medical, Elmed Electronics & Medical Systems S.A., Dornier MedTech, OPCOM, AED.MD and others. etc. Considering the increasing demand from global markets various new entries are expected in the Disposable Ureteroscope Market at regional as well as global levels.

Download Disposable Ureteroscope Market Sample Report PDF: https://www.vantagemarketresearch.com/disposable-ureteroscope-market-1690/request-sample

Top Competitors:

Boston Scientific Corporation, Richard Wolf GmbH, Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz GmbH, Smith & Nephew Inc., Pentax Medical, Elmed Electronics & Medical Systems S.A., Dornier MedTech, OPCOM, AED.MD and others.

Understanding the Industry's Growth, has released an Updated report on the Disposable Ureteroscope Market. The report is mixed with crucial market insights that will support the clients to make the right business decisions. This research will help new players in the global Disposable Ureteroscope Market to sort out and study market needs, market size, and competition. The report provides information on the supply and market situation, the competitive situation and the challenges to the market growth, the market opportunities, and the threats faced by the major players.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/disposable-ureteroscope-market-1690/0

Full Analysis Of The Disposable Ureteroscope Market:

Key findings and recommendations point to vital progressive industry trends in the global Disposable Ureteroscope Market, empowering players to improve effective long-term policies.

The report makes a full analysis of the factors driving the development of the market.

Analyzing the market opportunities for stakeholders by categorizing the high-growth divisions of the market.

Questions answered in the report

-Who are the top five players in the global Disposable Ureteroscope Market?

-How will the global Disposable Ureteroscope Market change in the next five years?

-Which product and application will take the lion's share of the global Disposable Ureteroscope Market?

-What are the drivers and restraints of the global Disposable Ureteroscope Market?

-Which regional market will show the highest growth?

-What will be the CAGR and size of the global Disposable Ureteroscope Market during the forecast period?

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/disposable-ureteroscope-market-1690

Reasons to Purchase this Disposable Ureteroscope Market Report:

-Analysis of the market outlook on current trends and SWOT analysis.

-The geographic and country level is designed to integrate the supply and demand organizations that drive industry growth.

-Disposable Ureteroscope Industry dynamics along with market growth opportunities in the coming years.

-Disposable Ureteroscope Market value (million USD) and volume (million units) data for each segment and sub-segment.

1 year consulting for analysts along with development data support in Excel. Competitive landscape including market share of major players along with various projects and strategies adopted by players in the last five years.

Market segmentation analysis including qualitative and quantitative analysis including the impact on financial and non-economic aspects.

Complete company profiles that include performance presentations, key financial overviews, current developments, SWOT analyzes and strategies used by major Disposable Ureteroscope Market players.

Check Out More Reports

Global Surgical Equipments Market:  Report Forecast by 2032

Global Cables and Accessories Market: Report Forecast by 2032

Global Bakery Processing Equipment Market: Report Forecast by 2032

Global Silicon Photomultipliers Market: Report Forecast by 2032

Global Exoskeleton Market: Report Forecast by 2032

[globalinsightblog]

Wearable Lung Function Monitors Market: Growing from $3.9B to $8.7B by 2034

Wearable Lung Function Monitors Market is set to surge from $3.9 billion in 2024 to $8.7 billion by 2034, growing at a CAGR of 8.5%. These cutting-edge devices provide real-time respiratory health tracking, enabling early diagnosis and management of conditions like asthma, COPD, and other pulmonary diseases.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS11156 &utm_source=SnehaPatil&utm_medium=Article

Market Dynamics & Key Segments

🔹 Spirometers lead the market, playing a crucial role in diagnosing and monitoring lung conditions. 🔹 Peak flow meters follow closely, offering effective tracking for asthma patients. 🔹 The rise of AI-powered wearable devices enhances remote monitoring and telehealth applications.

Regional Insights

🌎 North America dominates, backed by advanced healthcare infrastructure and high device adoption. 🌍 Europe follows, driven by strong healthcare investments and patient-centric care. 🇺🇸 The U.S. leads globally, with a well-established medical device industry and supportive policies. 🇩🇪 Germany ranks second, leveraging technological innovations and an aging population’s needs.

Growth Drivers

✅ Rising respiratory diseases boost demand for early diagnostics. ✅ Advancements in sensor technology & AI improve accuracy and convenience. ✅ Telemedicine integration accelerates remote monitoring adoption.

As healthcare shifts towards preventive and personalized solutions, wearable lung function monitors will redefine respiratory care in the coming years.

📢��Stay ahead in the respiratory health revolution!

#WearableTech #LungHealth #MedTech #RespiratoryCare #DigitalHealth #COPD #AsthmaCare #Spirometry #HealthcareInnovation #MedicalDevices #RemoteMonitoring #AIinHealthcare #Telemedicine #ConnectedHealth #SmartDevices #WellnessTech #HealthcareTrends #HealthTech #PatientCare #PersonalizedHealthcare #DigitalTransformation #PulmonaryCare #PreventiveHealthcare #IoTHealthcare #MedicalWearables #FutureOfHealth

[lovelypol]

Insulin Storage Devices Market: Doubling to $2.5 Billion by 2033 💉📊

Insulin Storage Devices Market focuses on innovative solutions designed to maintain the efficacy of insulin by ensuring optimal storage conditions. Key products include refrigerated storage units, portable cooling cases, and temperature-controlled containers. These devices play a critical role in the management of diabetes, offering patients convenient, reliable methods for insulin storage. As the prevalence of diabetes increases, advancements in storage technology are driving growth in this market, enhancing patient compliance and health outcomes.

To Request Sample Report : https://www.globalinsightservices.com/request-sample/?id=GIS26359 &utm_source=SnehaPatil&utm_medium=Article

In 2023, the insulin storage devices market reported a volume of 320 million units, with projections indicating a rise to 500 million units by 2033. Refrigerated storage units lead the market, holding a dominant 45% share, followed by non-refrigerated units at 35%, and portable devices at 20%. The refrigerated segment benefits from advancements in technology, which ensure the maintenance of optimal temperature, critical for preserving insulin’s efficacy. Insulin pens are the top-performing sub-segment, offering ease of use, while insulin pumps follow closely, as they provide precise dosages and better patient compliance.

Regionally, North America leads the market, supported by a well-established healthcare infrastructure and a significant diabetic population. Europe follows as the second-highest performing region, with rising awareness about diabetes management and favorable government initiatives. Meanwhile, the Asia-Pacific region is emerging as a high-growth market, driven by increased healthcare expenditure and rising disposable incomes in countries like China and India.

Leading players in the market, including Medtronic, Novo Nordisk, and Sanofi, are driving innovation in insulin storage solutions, expanding their product offerings and geographical presence. A projected 10% annual increase in R&D investment by 2033 is expected to foster further growth.

#DiabetesManagement #InsulinStorage #HealthcareInnovation #PortableStorage #SmartStorage #InsulinPens #DiabetesCare #InsulinTherapy #HealthTech #SmartDevices #TemperatureControl #RefrigeratedStorage #GlobalHealthcare #PatientCompliance #MedTech

[credenceresearchdotblog]

The global demand for shock wave therapy was valued at USD 1186.5 Million in 2022 and is expected to reach USD 2069.31 Million in 2030, growing at a CAGR of 7.2% between 2023 and 2030.Shock wave therapy, a non-invasive treatment modality, has gained considerable traction in the medical field over recent years. This innovative approach, primarily used for musculoskeletal disorders, has expanded into various therapeutic areas, presenting promising opportunities in the healthcare market. This article explores the current landscape of the shock wave therapy market, recent trends, technological advancements, and future prospects.

Browse the full report at https://www.credenceresearch.com/report/shock-wave-therapy-market

Understanding Shock Wave Therapy

Shock wave therapy involves the application of acoustic waves to targeted areas of the body to promote healing and reduce pain. The therapy utilizes high-energy shock waves to stimulate cellular repair and regeneration, alleviate inflammation, and enhance tissue repair. It is commonly employed for treating conditions such as plantar fasciitis, tendinitis, and calcific shoulder tendinopathy, among others.

Market Overview and Growth Drivers

The global shock wave therapy market has been experiencing robust growth, driven by several key factors:

1. Rising Prevalence of Musculoskeletal Disorders: An increase in the incidence of musculoskeletal disorders due to aging populations and active lifestyles has boosted the demand for effective and non-invasive treatment options like shock wave therapy.

2. Growing Awareness and Adoption: Increasing awareness among patients and healthcare providers about the benefits of shock wave therapy has led to its wider acceptance and adoption. The therapy's non-invasive nature, coupled with its potential for quicker recovery times, has contributed to its popularity.

3. Technological Advancements: Continuous advancements in shock wave therapy technology have led to the development of more efficient and precise devices. Innovations such as focused shock wave therapy and radial shock wave therapy have enhanced the efficacy of treatments and expanded their applicability.

4. Expanding Applications: Initially used primarily for musculoskeletal conditions, shock wave therapy has found applications in other areas such as urology (for treating kidney stones) and dermatology (for treating cellulite and scars). This diversification has opened new revenue streams and market opportunities.

Key Players

Dornier MedTech

Shockwave Medical Inc

BTL Industries

EDAP TMS

Boston Scientific Corporation

Bio-Med Inc

Inceler Medikal Co. Ltd

Karl Storz SE & Co. KG

EMS Dolorclast

Others

Segmentation

By Technology

Electrohydraulic Shock Wave Therapy (ESWT)

Electromagnetic Shock Wave Therapy (ESWT)

Piezoelectric Shock Wave Therapy

By Application

Orthopedic Conditions

Urology

Cardiology

Dermatology

Physiotherapy and Sports Medicine

Veterinary Medicine

By End-User

Hospitals

Clinics and Rehabilitation Centers

Sports and Fitness Centers

Veterinary Clinics

Home Use Devices

By Type of Shock Wave

Focused Shock Waves

Radial Shock Waves

Low-Energy Shock Waves

High-Energy Shock Waves

By Patient Age Group

Pediatric

Adult

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/shock-wave-therapy-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[deshpandeisha]

How Ablation Systems Work: Mechanisms and Techniques Explained

The global ablation systems market size was USD 5.75 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.6% during the forecast period. Increasing integration of ablation systems with imaging technologies and rising adoption of robotics and navigation technologies are major factors driving market revenue growth.

The Ablation Systems Market added by Emergen Research offers a comprehensive analysis of the recent advancements in the Ablation Systems industry and trends driving the growth of the market. It is an investigative study covering analysis of market drivers, restraints, challenges, threats, and growth prospects in the global Ablation Systems market. The global Ablation Systems market report is a methodical research of the Ablation Systems market done by extensive primary and secondary research. The fundamental purpose of the Ablation Systems market report is to offer an accurate and strategic analysis of the Ablation Systems business sphere.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/2557

Competitive Terrain:

The global Ablation Systems industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Medtronic, Johnson & Johnson, Abbott, Boston Scientific Corporation, AngioDynamic, Olympus, Smith+Nephew, Stryker, Dornier MedTech, and Cynosure, LLC

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Ablation Systems market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Ablation Systems market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Ablation Systems market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/2557

Market Segmentations of the Ablation Systems Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Ablation Systems market on the basis of product, application, and region:

Segments Covered in this report are:

Device Technology Outlook (Revenue, USD Billion; 2019-2032)

Radiofrequency (RF) Devices

Ultrasound Devices

Others

Application Outlook (Revenue, USD Billion; 2019-2032)

Cancer Treatment

Ophthalmologic Treatment

Urological Treatment

Others

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals & Clinics

Ambulatory Surgical Centers (ASCs)

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/ablation-systems-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/2557

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[secretofresearch]

The Emissions Trading Market is Moving Towards Sustainability

Emissions trading enables participants to stay within the defined cap through trading of carbon credits. The regulated entities that emit less than their allowance can sell the extra allowances (carbon credits) as per their needs, making the whole process very flexible and cost-effective. With growing concerns around environmental sustainability and tightening regulations, emissions trading has emerged as an efficient tool for incentivizing investments in cleaner technologies and driving down emissions. The global Emissions Trading Market is expected to exhibit a CAGR of 6.8% over the forecast period of 2024 to 2031.Key TakeawaysKey players operating in the Emissions Trading Market are Johnson & Johnson Services, Inc., 3M, Baxter, Coloplast A/S, Integra LifeSciences, Medtronic, Omeza, Cardinal Health, Bactiguard AB, Noventure, Essity, Schulke & Mayr GmbH, Smith & Nephew Plc., Convatec Group PLC, SANUWAVE and SANUWAVE Health, Inc., EO2 Concepts, Wound Care Advantage, LLC., Healthium Medtech Limited, Arch Therapeutics, Inc., Hydrofera, Sanara MedTech Inc., Axio Biosolutions Pvt Ltd., and Gentell, Inc. Major players are focusing on forming strategic partnerships and collaborations to develop advanced carbon credit trading platforms. The Emissions Trading Market Demand is witnessing significant due to strict regulations and incentives towards reducing industrial emissions. Growing awareness about environmental sustainability is encouraging more organizations to participate in emissions trading programs. The market is also benefiting from involvement of large corporates aiming to achieve carbon neutrality through carbon offsetting.Market Key TrendsOne of the key trends gaining traction in the emissions trading market is the transition towards digital marketplaces and blockchain-based carbon trading platforms. Blockchain offers advantages like transparency, security and automation in carbon credit transactions. It facilitates seamless peer-to-peer trading of emission allowances and offsets between regulated entities and project developers. Major players are making investments in distributed ledger technologies to modernize existing cap-and-trade schemes and attract more participants to carbon markets. The shift towards blockchain-based infrastructure is expected to boost overall efficiency, drive higher trading volumes and uphold integrity in the carbon credit distribution process.Porter’s AnalysisThreat of new entrants: High capital requirement and stringent regulations make entry difficult for new players. Bargaining power of buyers: Large buyers can negotiate better prices due to their scale of operation.Bargaining power of suppliers: Suppliers have low bargaining power due to availability of substitutes.Threat of new substitutes: Alternate technologies for carbon capture pose threat of substitution.Competitive rivalry: Intense competition exists among existing players to gain market share.Geographical concentration: The emissions trading market in Europe accounts for over 80% share in terms of value currently, primarily driven by stringent emission reduction targets.Get more insights on Emissions Trading MarketAbout Author:Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[lifesciencemarketresearch]

Data Reveals That APAC's Medtech Market is Poised for Explosive Growth

The Asia-Pacific (APAC) region is rapidly emerging as a powerhouse in the global medtech market. According to our Global Market Analysis and Projections (MAP) Database, APAC is the second largest regional medtech market, boasting an estimated market size of $131 billion in 2023. This impressive figure is made more notable by the region’s rapid growth, with our medtech market intelligence team projecting APAC to experience nearly double the compound annual growth rate (CAGR) of both the United States and Europe. Specifically, APAC is projected to grow at a robust CAGR of 8.4% from 2023 to 2028. For more information visit https://www.4shared.com/photo/dfpZFs2uge/Data_Reveals_That_APACs_Medtec.html

[thebusinessmagnate]

Joerg Dreisewerd: Pioneering Operations and Expansions of World-Class Medical Equipment and Consumables at SARSTEDT in Brazil

The Business Magnate. Joerg Dreisewerd, Managing Director (Brazil) and Regional Manager (Latin America), SARSTEDT. A German-based medical equipment and consumables manufacturer and distributor, SARSTEDT manufactures cutting-edge and world-class equipment and consumables for the Medical or MedTech industries. Such manufacturing industries in the medical sector design different medical equipment and a diverse range of products for hospitals, research institutes, academic institutions, industrial facilities, and surgical environments. The manufactured products and equipment are used to diagnose, monitor, and treat diseases and other medical conditions. In this article, we will be shedding light on SARSTEDT’s first South American branch located in Brazil, and how its current Managing Director – Joerg Dreisewerd, initiated and is leading operations and expansions in Latin America. Through Joerg’s impactful strategies and implementations in achieving company goals and visions as well as pioneering operations in medical supplies in Brazil, the Managing Director has successfully positioned the firm as a global manufacturer and healthcare solutions supplier. 

SARSTEDT – Company Overview:

SARSTEDT Group – the medical equipment and consumables manufacturer and distributor, is a German-based company with its head office established in Nümbrecht, North Rhine-Westphalia, Germany. The company was founded in 1961 by Walter Sarstedt who laid the foundation for this now renowned and globally recognized family business. SARSTEDT Group has over 15 production sites all across the globe in Europe, North America, South America, and Australia. The company opened its first Latin American branch in 1998 in Sao Paulo, Brazil, South America, and this expansion to Brazil was yet another successful milestone completed by the company in that year following Europe in 1971, the US in 1973, and Australia in 1991. The SARSTEDT Group, a healthcare industry leader in Brazil commenced its sales operations in what is now the world’s largest health market in in the Latin American country. 

SARSTEDT Products Manufactured and Distributed: 

The worldwide partner in Medicine and Science – SARSTEDT innovates the type of medical and laboratory products and other equipment, establishing a goal to move people forward. The company is one of the leading suppliers in the industry and develops, produces, and sells equipment and consumables to markets all around the globe. The various equipment and consumables manufactured are all state-of-the-art, technology-integrated, safe, high-quality, and high-performance products. SARSTEDT’s medical equipment in Brazil are categorized from Diagnostics (pre-analytical processes), Laboratory (solutions for molecular biology, biochemistry, cell biology, and more), and Clinic and Transfusion (clinical care), to Laboratory Automation (pre&post-analytical processes in clinical and microbiology areas). The various products developed and designed in each category will be mentioned below. 

Diagnostics – products for clinics, doctor’s offices, medical laboratories, and blood banks. Multi-safe Disposal Boxes and Erythrocyte Sedimentation Rate Devices. Collecting, sampling, and storing material samples like saliva, blood, stool, and urine are also available in Sample Collection Systems/Products.

Laboratory – for applications in molecular biology, biochemistry, and cell biology. Following certified SARSTEDT quality standards like PCR Performance Tested, Biosphere ® plus, TC-Tested, and Cryo Performance Tested, the products manufactured and designed for clean room conditions and automated production processes are Reagent and Centrifuge Tubes, The Multiply ® PCR, Molecular Biology, Micro Screw Tubes and Reaction Vessels, Liquid Handling (transfer pipettes, serological pipettes, and pipette tips), Cell and Tissue Culture Products, General Laboratory Items, DNA-free Forensic Swabs, Stands, Storage Boxes, Air Samplers, Table Centrifuges with Swing-Out Motor, Mixing Systems/Devices. 

Clinic and Transfusion – for clinical care and transfusion product segments, the products designed in this category are Urine Drainage Measuring Systems/Products, Hygiene Utensils, Warming Devices of the SAHARA product group, Sterile Closing and Stripping Devices of Blood Bag Tubes. 

Laboratory Automation – for pre and post-analytical processes in clinical and microbiological laboratories in Sample Feeding, Sample Identification, Decapping of Samples, Aliquoting, Recapping, Sorting, Distributing, and Archiving. The products manufactured and designed are Tube Labelers, Tempus600 Sample Transport System, Compact Sorters, Modular Pre and Post-Analytical Systems/Products, and the S4DX System.

Joerg Dreisewerd – The Man Pioneering and Leading Brazil’s Operations:

Joerg Dreisewerd is the Managing Director at SARSTEDT Group’s Brazil operation branch and also Latin America’s Regional Manager. Joerg has a Bachelor’s in Business Administration from the University of Applied Scinces for Business (FHDW) and was awarded best student in class during his MBA in Business Management from FGV – Fundação Getulio Vargas. The Managing Director started his career as Project Manager and later took on his current role at SARSTEDT Group Brazil in 2017. Joerg has worked in the healthcare industry for 15 years, and at SARSTEDT Group in Latin America oversaw a range of diverse responsibilities from company restructuring, turnarounds, and strategizing and implementing ESG actions in all three large, medium, and small businesses in the region. 

Initiating and leading SARSTEDT Group’s operations in Brazil, Joerg helped expand the the company’s position as a globally recognized manufacturer and distributor of hospital and laboratory equipment and consumables. By offering value-added products for customers, partners, and stakeholders of the management, Joerg envisions improving healthcare services and products regarding safety and quality. 

Joerg Dreisewerd’s Accolades from HarvardX:

Certification in “Improving Global health: Focusing on Quality and Safety”.

Certification in “LEAD1x: Exercising Leadership: Foundational Principles”. 

SARSTEDT Group’s Achievements Under Joerg Dreisewerd’s Leadership:

Joerg helped facilitate an organizational and cultural transformational transition of the Brazil branch from a centralized management to a modern governance structure. This led the company to be awarded the “Selo Paulista de Diversidade” in 2022 “Great Place to Work” in 2023 and 2024. 

The Managing Director helped the company position itself as medical solutions supplier withing the country’s main healthcare groups and for this SARSTEDT was awarded the “Top 3 Laboratory Supplier Hospital Albert Einstein Group” in 2019, 2020, 2021, and 2023. 

The “Best Laboratory Supplier of Grupo Fleury” was also awarded from 2021 – 2023.

Awarded the “Premio ECO 2023” by the Amcham São Paulo – American chamber of commerce, for Joerg’s implementation of ESG strategies and actions that established SARSTEDT as a pioneer in a Circular economy Project for pre-analytical healthcare consumables called – Caixa Magica (Magic Box).

Visit More : https://thebusinessmagnate.com/joerg-dreisewerd-pioneering-operations-and-expansions-of-world-class-medical-equipment-and-consumables-at-sarstedt-in-brazil/